Clinical analysis on Shengmai Injection in treating radiation pneumonia and pulmonary fibrosis

姚春筱
DOI: https://doi.org/10.3760/cma.j.issn.0254-5098.2004.01.019
2004-01-01
Abstract:目的 观察生脉注射液对于放射治疗后放射性肺炎和肺纤维化的防治效果.方法96例胸部肿瘤患者随机分为治疗组和对照组各48例,所有病例均接受根治性放疗,治疗组放疗同时应用生脉注射液40~60ml加入5%葡萄糖注射液中静脉点滴.结果治疗组放射性肺炎和肺纤维化发生率分别是18.8%和16.7%;对照组的发生率分别为37.5%和35.4%,两组比较,差异有显著性(P<0.05).结论生脉注射液能够降低放射性肺损伤的发生率。
What problem does this paper attempt to address?